Literature DB >> 1753126

Central venous line infection caused by Brevibacterium epidermidis.

C McCaughey, N N Damani.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1753126     DOI： 10.1016/0163-4453(91)92451-a

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  14 in total

1.  Characterization of Brevibacterium spp. from clinical specimens.

Authors:  E Gruner; G E Pfyffer; A von Graevenitz
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

2.  Brevibacterium casei sepsis in an 18-year-old female with AIDS.

Authors:  P Brazzola; R Zbinden; C Rudin; U B Schaad; U Heininger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Brevibacterium species as a cause of osteomyelitis in a neonate.

Authors:  B Neumeister; T Mandel; E Gruner; G E Pfyffer
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

5.  Differentiation of Brevibacterium spp. encountered in clinical specimens.

Authors:  G Funke; A Carlotti
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

6.  Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patient.

Authors:  R R Reinert; N Schnitzler; G Haase; R Lütticken; U Fabry; K P Schaal; G Funke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

7.  Bacteremia caused by Brevibacterium species in an immunocompromised patient.

Authors:  S S Kaukoranta-Tolvanen; A Sivonen; A A Kostiala; P Hormila; M Vaara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

8.  Human infections caused by Brevibacterium casei, formerly CDC groups B-1 and B-3.

Authors:  E Gruner; A G Steigerwalt; D G Hollis; R S Weyant; R E Weaver; C W Moss; M Daneshvar; J M Brown; D J Brenner
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

9.  Successful Treatment of Brevibacterium Bacteremia Solely With Antimicrobial Therapy.

Authors:  Charles E Benson; Luis Tatem
Journal:  Cureus       Date:  2021-06-28

10.  Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov.

Authors:  Sahare Kokcha; Dhamodharan Ramasamy; Jean-Christophe Lagier; Catherine Robert; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.